Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.

Delgrange, E; Sassolas, G; Perrin, G; Jan, M; Trouillas, J

Delgrange, E; Sassolas, G; Perrin, G; Jan, M; Trouillas, J.

Affiliation

Delgrange E; Department of Internal Medicine, Mont-Godinne Hospital, Université Catholique de Louvain, Louvain, Belgium. etienne.delgrange@mint.ucl.ac.be

Acta Neurochir (Wien) ; 147(7): 751-7; discussion 757-8, 2005 Jul.

Article in En | MEDLINE | ID: mdl-15971099

Subject(s)

Bromocriptine/therapeutic use; Dopamine Agonists/therapeutic use; Pituitary Neoplasms/surgery; Prolactinoma/surgery; Adult; Aged; Bromocriptine/adverse effects; Dopamine Agonists/adverse effects; Drug Resistance; Female; Humans; Hypophysectomy; Ki-67 Antigen/analysis; Magnetic Resonance Imaging; Male; Middle Aged; Mitotic Index; Neoplasm Invasiveness/pathology; Neoplasm Staging; Pituitary Gland/pathology; Pituitary Neoplasms/diagnosis; Pituitary Neoplasms/pathology; Prolactinoma/diagnosis; Prolactinoma/pathology; Retrospective Studies; Sex Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Prolactinoma / Bromocriptine / Dopamine Agonists Type of study: Diagnostic_studies / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Neurochir (Wien) Year: 2005 Document type: Article Affiliation country: Belgium Country of publication: Austria

Search on Google

Add to My VHL

XML

PubMed Links